ArticleBMC geriatrics2025
Emergence of co-infection with Cryptococcus neoformans and Acinetobacter baumannii in older people with systemic lupus erythematosus.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Systemic lupus erythematosus (SLE) is a common autoimmune disease affecting various organs. Cryptococcus neoformans, an environmental yeast that is heavily dependent on the complement cascade for natural host defense, is produced via inhalation in immunocompromised patients. The fungal pathogen, C. neoformans, can cause life-threatening infections in patients with SLE. Acinetobacter baumannii is a nosocomial pathogen that causes healthcare-associated infections, particularly in immunocompromised and critically ill patients. However, reports of co-infection with C. neoformans and A. baumannii in patients with SLE are scarce. We report an interesting case of co-infection with C. neoformans and A. baumannii in an 85-year-old man presented with cough, expectoration, chest tightness, and shortness of breath five months after diagnosis of SLE. The patient recovered gradually after 18 days of antimicrobial therapy. Coinfection with C. neoformans and A. baumannii in patients with SLE is rare, difficult to diagnose early, and has a high mortality rate. Accurate diagnosis and timely treatment are lifesaving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.